Location History:
- Fleurieux Sur L'Arbresle, FR (1998)
- sur l'Arbresle, FR (2000)
- Saint-Germain-sur-l'Arbresle, FR (1999 - 2001)
Company Filing History:
2 out of 16 
1 out of 6 
1 out of 1 Years Active: 1998-2001
Title: The Innovative Contributions of Bernard Fanget
Introduction
Bernard Fanget, an accomplished inventor residing in Saint-Germain-sur-l'Arbresle, France, has made significant strides in the field of vaccine technology. With a total of four patents to his name, Fanget's work focuses on developing innovative stabilizers for vaccines, enhancing their effectiveness and safety.
Latest Patents
Fanget's latest patents include groundbreaking innovations in stabilizers for live vaccines. His patents detail methods for preparing stabilized vaccines that contain attenuated mono- or multivalent live viruses. These stabilizers comprise components from several groups, including amino acids, disaccharides, polyalcohols, and buffer solutions, ensuring the integrity and viability of the vaccines. Notably, one of the components selected from the disaccharide group is saccharose. Additionally, he has worked on the industrial production process for vaccines aimed at combating Japanese diseases, further solidifying his impact in the pharmaceutical sector.
Career Highlights
Throughout his career, Fanget has contributed to the advancement of vaccine technology while working at prestigious organizations such as Pasteur Merieux Serums Et Vaccins and Pasteur Merieux Serums & Vaccins. His expertise and innovative mindset have played a crucial role in the development of effective vaccination methods.
Collaborations
Fanget has collaborated with notable professionals in the field, including Alain Francon and Pierre Heimendinger. These partnerships have fostered an environment of creativity and innovation, allowing Fanget to explore new avenues in vaccine stabilization and production.
Conclusion
Bernard Fanget's contributions to the field of vaccine technology showcase his dedication to innovation and public health. As he continues to develop new solutions for vaccine stabilization, his work remains vital in the ongoing fight against infectious diseases. His patents not only reflect his inventive spirit but also the collaborative efforts that drive advancements in medical research.